NCT07234500Completed
Evaluation of a Mobile Application Designed to Support Type 1 Diabetic Patients in Adjusting Their Insulin Doses.
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
Title: Evaluating a Mobile Application for Insulin Management in Iraqi Type 1 Diabetes Patients. The goal of this clinical trial is to determine whether a mobile health application can improve insulin management and blood sugar control in Iraqi patients with Type 1 Diabetes aged over 15 years who are on intensive insulin therapy. The main question it aims to answer is: Does the use of the mobile application lead to a greater reduction in HbA1c levels compared to standard care alone? Researchers will compare the group using the mobile application to the group receiving standard care alone to see if the application is more effective at improving glycemic control. Participants will be assigned to one of two groups for the 3-month study. Either use the mobile application to guide their daily insulin dose adjustments alongside standard care, or receive standard care alone. Undergo blood tests (including HbA1c) and complete questionnaires about hypoglycemic events, insulin adherence, and quality of life.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 27 Sept 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- University of Baghdad
- Diseases
- Type 1 diabetes
- NCT number
- NCT07234500
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 1 Sept 2025 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with psychiatric disorders.
Other
- Pregnant woman or planning to be pregnant
- Patients at high risk of developing hypoglycemia (e.g., those with IHD, osteoporosis, hypoglycemia unawareness).
- Patients who will be subjected to a major change in insulin dose (more than 20%) at the start or during the study period.
- Patients who don't use the application during the study period. The usage Metrics of the application will be watched on Google Analytics
Who the study is looking for
- Patients (≥15 years), with uncontrolled (HbA1c ≥ 7) type 1 diabetes who were treated with multiple daily insulin injections (MDI) for at least 3 months before the study date.
- Patients who are willing to test their blood glucose level at least 3 times daily during the study period.
- Participants who will give their informed consent to participate in the study. -
Age in the registry: 15 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faiha Specialized Diabetes, Endocrine and Metabolism Center at Al-Faiha Teaching hospital Coordinator of this site? Confirm its status | Basra | Iraq | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.